NCT07662837 Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.
| NCT ID | NCT07662837 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lahore University of Biological and Applied Sciences |
| Condition | PARKINSON DISEASE (Disorder) |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-05-30 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-05-30 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study has important clinical, academic, and practical relevance in neuromuscular rehabilitation. Clinically, it aims to identify effective and tolerable rehabilitation strategies for individuals with Parkinson's disease by comparing Tai Chi Therapy with Qi-Gong there by supporting evidence-based physiotherapy practice and improving patient adherence. Academically, it contributes to the limited literature on comparative effectiveness of these interventions and incorporates patient-centered outcomes such as exercise perception, which are often underreported. From a practical and societal perspective, identifying a more acceptable and effective approach may enhance long-term participation in rehabilitation, potentially slow disease progression, and reduce the overall healthcare burden associated with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: Diagnosis of PD based on the Hoehn \& Yahr staging system (Stages I). Male or female patients aged between 50-65 years. Currently receiving stable anti-Parkinsonian medication, with no changes in the treatment regimen for at least 3 months. Basic self-care ability with no severe cognitive impairment (Mini-Mental State Examination \[MMSE\] score ≥24). Exclusion Criteria: Depression, as assessed based on a score of \>16 for the Beck Depression Inventory-II (BDI-II). Recent deep brain stimulation (DBS) treatment. Use of medication that interferes with cognition, alertness, or attention. Current participation in an exercise training program.
Contact & Investigator
Salwa Atta
STUDY DIRECTOR
Lahore University of Biological & Applied Sciences
Frequently Asked Questions
Who can join the NCT07662837 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 65 Years, studying PARKINSON DISEASE (Disorder). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07662837 currently recruiting?
Yes, NCT07662837 is actively recruiting participants. Contact the research team at maryamfayyazawan@gmail.com for enrollment information.
Where is the NCT07662837 trial being conducted?
This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.
Who is sponsoring the NCT07662837 clinical trial?
NCT07662837 is sponsored by Lahore University of Biological and Applied Sciences. The principal investigator is Salwa Atta at Lahore University of Biological & Applied Sciences. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.